You are here

  • Home
  • Archive
  • Volume 21, Issue Suppl 1
  • DI-033 Safety profile study of planned randomised conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients

Citation Tools

Article menu
Download PDFPDF
Drug Information and Pharmacotherapy
DI-033 Safety profile study of planned randomised conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Felix M, Felipe C, Tedesco-Silva H, et al
DI-033 Safety profile study of planned randomised conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients
European Journal of Hospital Pharmacy 2014;21:A83.